Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Bullboard Posts
Comment by Indomitableon Jul 15, 2016 7:45pm
45 Views
Post# 25057876

RE:RE:More google translated snippets "StockWorld"

RE:RE:More google translated snippets "StockWorld"I read my post here I wrote this morning and in tetrospect I see how I erred in my thinking. Their outstanding shares did increase with PP's they have had. My bad. Sorry about that. I admit my mistake. I am just a noob trader,, only been trading since Jan 1st of this year,  to begin with, and I am a slow learner. 

Still regardless, Lee did say in a not to long ago video that their finances are covered for a year, and they do have the 30 million milestone payments from Shiseido plus royalities. Plus they have another company they are working with that probably owes them money as well. I have to do further DD to get the specifics. Don't have time now.

I was googling today on Replicel and saw this German video that was dated one day ago that was about 20 minutes long, with them all talking about Replicel. i couldn't get the video to translate properly otherwise I would have posted it here in this forum. I was thinking they were possibly the other company. My memory fails me now as to who the other company was because my dd on Replicel has been quite some time since that info was available to me. I forget info quite fast. 

Sorry to post so much. Sorry for any mistakes I make in my posting. I will try to do my best to keep my info as accurate and true as possible. If I catch my mistake I will correct it. I'm just trying to help all with their dd.

Regardless of anything I continue to hold long term in this company. Not a lot of money mind you as I am poor however for me it is just enough to put a noticable dent in my tiny total RDSP amount.  

GLTA whoever is in this stock and holding long term. Anything can happen with stocks especially when they are companies in their infancy or who haven't made it to a certain milestone. It truly can be tough trying to tell which way a share price is going to move, turn or stay at. DD helps figure that out. 

You all have a good weekend.now...
Indomitable Cool
Bullboard Posts